Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5120030 | 6123770 | F | 1 | 5120030-4 | 20060723 | 20060919 | 20060929 | EXP | 2006100402 | PFIZER INC | 51 | YR | F | N | 20060928 | OT | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5120030 | 1007726844 | PS | SULFASALAZINE | 1 | ORAL | 2 GRAM (500 MG, EVERY DAY), ORAL | D | D | 7073 | ||
| 5120030 | 1007745784 | SS | NAPROSYN | 1 | ORAL | ORAL | Y | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5120030 | 1007726844 | DRUG USE FOR UNKNOWN INDICATION |
| 5120030 | 1007745784 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5120030 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5120030 | CYTOLYTIC HEPATITIS |
| 5120030 | DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
| 5120030 | HYPERSENSITIVITY |
| 5120030 | OEDEMA PERIPHERAL |
| 5120030 | TOXIC SKIN ERUPTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5120030 | FGN |
| 5120030 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5120030 | 1007726844 | 20060623 | 20060723 | ||
| 5120030 | 1007745784 | 20060605 | 20060723 |